Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface
- 1 January 1996
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 313 (1) , 235-239
- https://doi.org/10.1042/bj3130235
Abstract
Extracellular-superoxide dismutase (EC-SOD) levels in sera divide into two discontinuous groups: a low-level group below 400 ng/ml and a high-level group above 400 ng/ml [Adachi, Nakamura, Yamada, Futenma, Kato and Hirano (1994) Clin. Chim. Acta 229, 123-131]. Molecular genetic studies have shown that the donors in the high-level group have a single base substitution generating the exchange of glycine for arginine-213 (R213G) in the heparin-binding domain of EC-SOD [Sandström, Nilsson, Karlsson and Marklund (1994) J. Biol. Chem. 269, 19163-19166; Yamada, Yamada, Adachi, Goto, Ogasawara, Futenma, Kitano, Hirano and Kato (1995) Jpn. J. Hum. Genet. 40, 177-184]. The serum EC-SOD level in homozygote subjects was significantly higher than that in heterozygotes and in normal subjects. Serum EC-SOD from heterozygotes and homozygotes had equally decreased affinity for heparin, as judged by heparin-HPLC, as compared with that from normal donors. This result suggests that the serum EC-SOD in heterozygotes was mainly composed of the mutant form which has reduced heparin affinity. On the other hand, fibroblast cells derived from heterozygote subjects generated mRNA of both normal and mutant EC-SOD (m-EC-SOD), and expressed the corresponding proteins. EC-SOD is a tetrameric enzyme, and in heterozygote donors would be heterogeneous with regard to the constitution of normal and mutant subunits. The enzyme form consisting of only mutant subunits, the form with the weakest heparin affinity, can be preferentially driven out to the plasma phase, because EC-SOD in the vasculature exists in equilibrium between plasma and the endothelial cell surface. The binding of m-EC-SOD to bovine aortic endothelial cells was about 50-fold less than that of normal EC-SOD. This result suggests that the binding of m-EC-SOD to vascular endothelial cells is much decreased in vivo, which causes a high level of serum EC-SOD.Keywords
This publication has 25 references indexed in Scilit:
- Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serumJournal of Human Genetics, 1995
- Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1994
- Internalization of human extracellular-superoxide dismutase by bovine aortic endothelial cellsFree Radical Biology & Medicine, 1994
- Pedigree of serum extracellular-superoxide dismutase levelClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- The nature of heterogeneous components of extracellular-superoxide dismutase purified from human umbilical cordsFree Radical Biology & Medicine, 1993
- Molecular analysis of five independent Japanese mutant genes responsible for hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencyHuman Genetics, 1992
- Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibodyClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- The heparin binding site of human extracellular-superoxide dismutaseArchives of Biochemistry and Biophysics, 1992
- Plasma clearance of human extracellular-superoxide dismutase C in rabbits.Journal of Clinical Investigation, 1988
- Superoxide dismutase in extracellular fluidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1982